All products on this site are for in-vitro research, research use only. Products are not for human consumption of any kind.

Detection and in vitro metabolism of AOD9604

“Detection and in vitro metabolism of AOD9604”​1​

  1. 1.
    Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection andin vitrometabolism of AOD9604. Drug Test Analysis. Published online September 10, 2014:31-38. doi:10.1002/dta.1715


 

  • AOD9604

    Daniel Eichner, Ph.D., President/Laboratory Director, has extensive anti-doping experience. Dr. Eichner was previously the Science Director at the United States Anti-Doping Agency (USADA). At USADA, he provided scientific support for USADA's programs in research, intelligence, sample collection planning, results management, arbitration and education. Prior to joining USADA, Dr. Eichner was the Chief Scientific Officer for the Australian Sports Anti-Doping Authority (ASADA). During his time at ASADA, he was a member of the Anti-Doping Research Program, Anti-Doping Ethical Review Board and an expert witness for numerous Australian Customs Investigations relating to steroid and performance-enhancing seizures. He received his B.S. from the Australian National University (ANU) with first class honors and later completed his Ph.D. in medical science from the ANU.

    Daniel Eichner has a PhD from the . Daniel Eichner PhD currently works at the and has 4 years experience in researching Detection and in vitro metabolism of AOD9604 at the . One of their notable works include "Detection and in vitro metabolism of AOD9604". Published online January 2015. doi:https://doi.org/10.1002/dta.1715 [PubMed]
    LinkedIn | University of Utah | Sports Medicine Research & Testing Laboratory